Short Report
Pediatric intraoperative ciliary block

https://doi.org/10.1016/j.jaapos.2021.02.007Get rights and content

Pediatric patients who undergo intraocular surgery are at risk for many of the same perioperative complications as adults. The same methodical approach to assessing perioperative shallowing of the anterior chamber that presents in the adult population should be followed for children. We present a rare case of intraoperative ciliary block in a 3-year-old boy undergoing a second glaucoma drainage device implantation that was successfully treated with pars plana vitrectomy and hyaloid-zonulo-iridectomy.

Section snippets

Case Report

A 3-year-old boy with primary congenital glaucoma in both eyes with a history of prior bilateral temporal rigid probe trabeculotomies, bilateral inferonasal glaucoma drainage devices, and bilateral cataract extraction with posterior capsulotomy, anterior vitrectomy, and intraocular lens (IOL) placement underwent routine examination under anesthesia at Bascom Palmer Eye Institute. His assessment was notable for median intraocular pressure (IOP) of 37 mm Hg in the right eye and 18 mm Hg in the

Discussion

Although glaucoma drainage device implantation is reasonably successful at controlling IOP, surgery in children can have similar complications as in adults, including tube exposure, malposition, and obstruction as well as endophthalmitis, retinal detachment, and phthisis.1 When confronted with perioperative shallowing of the anterior chamber, the differential diagnosis should first assess whether the IOP is reduced or elevated. If reduced, the surgeon should evaluate for a wound leak, and if

References (10)

There are more references available in the full text version of this article.

Cited by (0)

Financial support: Supported in part by NIH Center Core Grant P30EY014801, an unrestricted grant from Research to Prevent Blindness (GR004596), the Heed Ophthalmic Foundation (ALR), the 2019 University of Miami Institute for Advanced Study of the Americas Pilot Grant (TCC), and Grant Number UL1TR002736, Miami Clinical and Translational Science Institute (TCC).

View full text